These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 11796839)

  • 1. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
    Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
    Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
    Qian J; Bostwick DG; Takahashi S; Borell TJ; Herath JF; Lieber MM; Jenkins RB
    Cancer Res; 1995 Nov; 55(22):5408-14. PubMed ID: 7585610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?
    Cheng L; Leibovich BC; Bergstralh EJ; Scherer BG; Pacelli A; Ramnani DM; Zincke H; Bostwick DG
    Cancer; 1999 Jun; 85(11):2455-9. PubMed ID: 10357418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular cytogenetic analysis of 7q31 in prostate cancer.
    Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI
    Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
    Gburek BM; Kollmorgen TA; Qian J; D'Souza-Gburek SM; Lieber MM; Jenkins RB
    J Urol; 1997 Jan; 157(1):223-7. PubMed ID: 8976257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
    Takahashi S; Shan AL; Ritland SR; Delacey KA; Bostwick DG; Lieber MM; Thibodeau SN; Jenkins RB
    Cancer Res; 1995 Sep; 55(18):4114-9. PubMed ID: 7664288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.
    Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR
    Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dedifferentiation in the metastatic progression of prostate carcinoma.
    Cheng L; Slezak J; Bergstralh EJ; Cheville JC; Sweat S; Zincke H; Bostwick DG
    Cancer; 1999 Aug; 86(4):657-63. PubMed ID: 10440694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
    Takahashi S; Alcaraz A; Brown JA; Borell TJ; Herath JF; Bergstralh EJ; Lieber MM; Jenkins RB
    Clin Cancer Res; 1996 Jan; 2(1):137-45. PubMed ID: 9816100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic profile identification in clinically localized prostate carcinoma.
    Gallucci M; Merola R; Leonardo C; De Carli P; Farsetti A; Sentinelli S; Sperduti I; Mottolese M; Carlini P; Vico E; Simone G; Cianciulli A
    Urol Oncol; 2009; 27(5):502-8. PubMed ID: 18534873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic profiles as additional markers to pathological features in clinically localized prostate carcinoma.
    Gallucci M; Merola R; Farsetti A; Orlandi G; Sentinelli S; De Carli P; Leonardo C; Carlini P; Guadagni F; Sperduti I; Cianciulli AM
    Cancer Lett; 2006 Jun; 237(1):76-82. PubMed ID: 16002207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.